Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
Falini
Brunangelo
B
Institute of Hematology, University of Perugia, Ospedale S. Maria della Misericordia, S. Andrea delle Fratte, Perugia, Italy. faliniem@unipg.it
Martelli
Maria Paola
MP
Bolli
Niccolò
N
Sportoletti
Paolo
P
Liso
Arcangelo
A
Tiacci
Enrico
E
Haferlach
Torsten
T
D000818:Animals; D018703:Founder Effect; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification* / Q000175:diagnosis / Q000235:genetics*; D008954:Models, Biological; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D009154:Mutation / Q000502:physiology; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D000090243:Nucleophosmin; D011379:Prognosis
D050505:Mutant Proteins; C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin